← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1993Last known activity
Nov 26, 2024
Timeline
1950s
- Jan 1, 1952
Joslin Diabetes Center— Founded
Drugs by trial phase (28 distinct, 37 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Indications
Studied for
- Atherosclerosis
- Cardiovascular Diseases
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Edema
- Hypoglycemia
- Inflammation
- Insulin Resistance
- Kidney Diseases
- Kidney Failure, Chronic
- Macular Edema
- Myocardial Ischemia
- Obesity
- Overweight
- Retinal Diseases
Recent trials (50)
- NCT06986603Lead sponsorPhase 4Nov 26, 2024
- NCT06217302CollaboratorPhase 3Oct 15, 2024
- NCT06217302Lead sponsorPhase 3Oct 15, 2024
- NCT06217302OfficialPhase 3Oct 15, 2024
- NCT06217302Sponsor investigatorPhase 3Oct 15, 2024
- NCT04929379Overall official - principal investigatorPhase 2Oct 1, 2021
- NCT04929379Lead sponsorPhase 2Oct 1, 2021
- NCT04929379Sponsor investigatorPhase 2Oct 1, 2021
- NCT04409795Lead sponsorPhase 2/Phase 3Aug 31, 2020
- NCT03219411Lead sponsorPhase 2Aug 28, 2017
- NCT03219411Overall official - principal investigatorPhase 2Aug 28, 2017
- NCT03255629Lead sponsorPhase 1/Phase 2Aug 18, 2017
- NCT03255629Overall official - principal investigatorPhase 1/Phase 2Aug 18, 2017
- NCT02794155Overall official - principal investigatorPhase 2Jun 1, 2016
- NCT02660242Study chairPhase 2Jan 1, 2016
Details
- Founded
- Boston, MA, US Jan 1, 1952
- Last known activity
- Nov 26, 2024